Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
How Are Anti-VEGF Therapies Shaping the Choroidal Neovascularization Market?
Anti-VEGF therapies are the cornerstone of the choroidal neovascularization market. Drugs that inhibit vascular endothelial growth factor reduce abnormal blood vessel growth and leakage, preserving vision in patients with CNV. Since their introduction, these therapies have transformed treatment and expanded the market. In the choroidal neovascularization market, competition among anti-VEGF...
0 Commentaires ·0 Parts ·124 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!